Rituximab in Combination with Interferon-Alpha in Relapsed and Refractory Diffuse Large B-Cell Non-Hodgkin’s Lymphoma | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Rituximab in Combination with Interferon-Alpha in Relapsed and Refractory Diffuse Large B-Cell Non-Hodgkin’s Lymphoma

Acta Haematol (2001) 106 (3): 141–142.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Toll-like Receptor 4 Ligands Down-regulate Fcγ Receptor IIb (FcγRIIb) via MARCH3 Protein-mediated Ubiquitination

Kavin Fatehchand
Li Ren
Saranya Elavazhagan
Huiqing Fang
Xiaokui Mo
John P. Vasilakos
Gregory N. Dietsch
Robert M. Hershberg
Susheela Tridandapani
Jonathan P. Butchar

Journal of Biological Chemistry (2016) 291 (8): 3895.

CHOP-like regimen in combination with rituximab and peginterferon alpha-2b in newly-diagnosed diffuse large B-cell Non-Hodgkin’s lymphoma: Experience in a Chinese center

Shu-qing Lü
Jian-min Yang
Xian-min Song
Li Chen
Wei-ping Zhang
Xiao-qian Xu
Xiong Ni
Chong-mei Huang
Yi He
Jian-min Wang

Clinical Oncology and Cancer Research (2010) 7 (2): 103.

Treatment of Resistant/Relapsing Chronic Lymphocytic Leukemia with a Combination Regimen Containing Deoxycoformycin and Rituximab

S.N. Tsiara
H.D. Kapsali
A. Chaidos
L. Christou
K.L. Bourantas

Acta Haematologica (2004) 111 (4): 185.